It has been shown that proteinase-activated receptor 1 (PAR1) is involved both in the bleomycin-induced pulmonary fibrosis (Howell et al., 2005) and in the antifibrotic action of dabigatran (Bogatkevich et al., 2009). Here, F2R is linked to pulmonary fibrosis.